Skip to main content
Kenneth Tomkovich, MD, Radiology, Freehold, NJ

KennethRTomkovichMD

Radiology Freehold, NJ

Interventional Neuroradiology, Vascular & Interventional Radiology

Physician

Are you Dr. Tomkovich?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 52 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    901 W Main St
    Medical Arts Building
    Freehold, NJ 07728
    Phone+1 732-462-3302
    Fax+1 732-780-6213

Summary

  • Dr. Kenneth Tomkovich, MD is a board certified radiologist in Freehold, New Jersey. He is currently licensed to practice medicine in New Jersey and Colorado. He is affiliated with CentraState Healthcare System and Penn Medicine Princeton Medical Center.

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Vascular and Interventional Radiology, 1998 - 1999
  • Rutgers Health/New Jersey Medical School
    Rutgers Health/New Jersey Medical SchoolResidency, Radiology-Diagnostic, 1994 - 1998
  • Jersey Shore University Medical Center
    Jersey Shore University Medical CenterInternship, Transitional Year, 1993 - 1994
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 1993

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1995 - 2025
  • CO State Medical License
    CO State Medical License 1998 - 1999
  • American Board of Radiology Interventional Radiology and Diagnostic Radiology

Awards, Honors, & Recognition

  • Top MD Consumers Checkbook

Publications & Presentations

PubMed

Press Mentions

  • IceCure’s ProSense for Cryoablation Treatment of Breast Tumors Evaluated in Six Studies
    IceCure’s ProSense for Cryoablation Treatment of Breast Tumors Evaluated in Six StudiesOctober 7th, 2024
  • IceCure's ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal: ProSense® Cryoablation Without Excision for Early-Stage, Low-Risk Breast Cancer Demonstrates 96.3% Recurrence Free Rate
    IceCure's ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal: ProSense® Cryoablation Without Excision for Early-Stage, Low-Risk Breast Cancer Demonstrates 96.3% Recurrence Free RateSeptember 24th, 2024
  • IceCure's ProSense Featured in Poster Presentation at Radiological Society of North America's 2022 Annual Meeting
    IceCure's ProSense Featured in Poster Presentation at Radiological Society of North America's 2022 Annual MeetingNovember 30th, 2022
  • Join now to see all

Professional Memberships